Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The relative merits of cord blood as a cell source for autologous T regulatory cell therapy in type 1 diabetes.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme - 1 Jan 2015

Theil A, Wilhelm C, Guhr E, Reinhardt J, Bonifacio E

Abstract excerpt

Cord blood has been used as a cell source for therapeutic purposes in children with type 1 diabetes and other disorders. Here, we explore the benefits of cord blood as an autologous source of T regulatory cells for immune cell therapy in patients. CD4(+)CD25(+) T regulatory cells were isolated from cord blood and adult peripheral blood of healthy donors and compared during and after expansion in a 14-day protocol...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD4 Antigens
Share to Cell Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Separation

Share to Diabetes Mellitus, Type 1

Share to Fetal Blood

Share to Interleukin-2 Receptor alpha Subunit

Share to T-Lymphocytes, Regulatory

Share to Transplantation, Autologous

Source

Identifiers

PMID: 25372776
DOI: 10.1055/s-0034-1394372

Genes

FOXP3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The relative merits of cord blood as a cell source for autologous T regulatory cell therapy in type 1 diabetes.PMID 25372776Read ↗

Massive ex Vivo Expansion of Human Natural Regulatory T Cells (T <sub>regs</sub> ) with Minimal Loss of in Vivo Functional ActivitySemantic proximity Read ↗

Human Regulatory T Cells From Umbilical Cord Blood Display Increased Repertoire Diversity and Lineage Stability Relative to Adult Peripheral Blood.Semantic proximity Read ↗

Delineating phenotypic heterogeneity in human regulatory T cells across developmental stages and therapeutic sources.Semantic proximity Read ↗

Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.Semantic proximity Read ↗

Expansion of human regulatory T-cells from patients with type 1 diabetes.Semantic proximity Read ↗

The Yin and Yang of Type 1 Regulatory T Cells: From Discovery to Clinical Application.Semantic proximity Read ↗

Derivation of Induced Pluripotent Stem Cells from Human Peripheral Blood T LymphocytesSemantic proximity Read ↗

Rapamycin and abundant TCR stimulation are required for the generation of stable human induced regulatory T cellsSemantic proximity Read ↗

Isolation strategies of regulatory T cells for clinical trials: Phenotype, function, stability, and expansion capacitySemantic proximity Read ↗

Autologous Regulatory T Cells for the Treatment of Type 1 DiabetesSemantic proximity Read ↗

Deep sequencing of the TCR-β repertoire of human forkhead box protein 3 (FoxP3)+ and FoxP3- T cells suggests that they are completely distinct and non-overlapping.Semantic proximity Read ↗

A Comparison of Ex Vivo Expanded Human Regulatory T Cells Using Allogeneic Stimulated B Cells or Monocyte-Derived Dendritic Cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.